Related Experiment Video

Updated: Jun 23, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Left ventricular function and the timing of surgical treatment in valvular heart disease

J Ross

    Annals of Internal Medicine
    |April 1, 1981
    PubMed

    Insights

    Surgical intervention for valvular heart disease may be recommended to preserve left ventricular function, especially in cases of aortic regurgitation and chronic mitral regurgitation with specific indicators of cardiac strain.

    Area of Science:

    • Cardiology
    • Cardiac Surgery
    • Cardiovascular Medicine

    Background:

    • Determining optimal timing for surgical intervention in valvular heart disease to prevent irreversible left ventricular damage remains a clinical challenge.
    • Left ventricular (LV) function is crucial for long-term outcomes in patients with valvular heart disease.

    Purpose of the Study:

    • To evaluate the indications for surgical treatment of valvular heart disease, focusing on the preservation of left ventricular function.
    • To clarify when valve replacement or repair should be considered even in the presence of minimal symptoms.

    Main Methods:

    • Review of clinical outcomes and left ventricular function following surgical intervention for aortic stenosis, aortic regurgitation, and chronic mitral regurgitation.
    • Analysis of factors such as left ventricular size, ejection fraction, and symptom severity in relation to postoperative function.

    Main Results:

    • In aortic stenosis, LV function typically improves post-aortic valve replacement, suggesting surgery is not solely indicated for prevention of dysfunction.
    • In aortic regurgitation, surgery is considered with progressive cardiomegaly and reduced systolic function, even with mild symptoms.
    • In chronic mitral regurgitation, impaired LV function postoperatively is noted with marked LV enlargement and mildly reduced ejection fraction, warranting consideration for early surgery.

    Conclusions:

    • Operative risks for valve replacement/repair are acceptably low.
    • Surgical intervention for valvular heart disease can be prioritized for preserving left ventricular function in specific clinical scenarios, particularly in aortic regurgitation and chronic mitral regurgitation.

    More Related Videos

    Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery04:48

    Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

    Published on: November 28, 2018

    Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

    Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

    Published on: June 15, 2020

    Related Concept Videos

    Mitral Regurgitation III: Medical Management01:25

    Mitral Regurgitation III: Medical Management

    Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...